w 7 has been researched along with 7-nitroindazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Etgen, GJ; Fryburg, DA; Gibbs, EM | 1 |
| Furukawa, T; Katsuragi, T; Kushiku, K; Noguchi, H; Ono, N; Yamada, H; Yamada, K | 1 |
| Cheng, KK; Lin, HC; Tseng, CJ; Wan, FJ | 1 |
3 other study(ies) available for w 7 and 7-nitroindazole
| Article | Year |
|---|---|
Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway.
Topics: 3-O-Methylglucose; Androstadienes; Animals; Calcium; Dantrolene; Dibutyryl Cyclic GMP; Enzyme Inhibitors; Female; Glucose; Indazoles; Muscle Contraction; Muscle, Skeletal; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Sulfonamides; Wortmannin | 1997 |
Contribution of nitric oxide to the presynaptic inhibition by endothelin ETB receptor of the canine stellate ganglionic transmission.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Animals; Antihypertensive Agents; Dogs; Endothelin Receptor Antagonists; Enzyme Inhibitors; Female; In Vitro Techniques; Indazoles; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oligopeptides; Oxadiazoles; Piperidines; Quinoxalines; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Stellate Ganglion; Sulfonamides; Synapses; Synaptic Transmission | 1999 |
Nitric oxide signaling pathway mediates the L-arginine-induced cardiovascular effects in the nucleus tractus solitarii of rats.
Topics: Aminoquinolines; Animals; Arginine; Blood Pressure; Calcium; Calmodulin; Cardiovascular System; Cyclic GMP-Dependent Protein Kinases; Guanylate Cyclase; Heart Rate; Indazoles; Isoquinolines; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; Solitary Nucleus; Solubility; Sulfonamides | 1999 |